Allergy Therapeutics
AGY.L
#6967
Rank
A$0.72 B
Marketcap
$0.14
Share price
6.06%
Change (1 day)
212.53%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2024: -A$77.86 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are A$69.84 Million. In 2024 the company made an earning of -A$77.86 Million, an increase over its 2023 earnings that were of -A$82.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024-A$77.86 Million-5.94%
2023-A$82.78 Million243.12%
2022-A$24.13 Million-403.33%
2021A$7.95 M-49.05%
2020A$15.6 M82.31%
2019A$8.56 M-159.83%
2018-A$14.32 Million255.37%
2017-A$4.03 Million-84.22%
2016-A$25.53 Million-1678.94%
2015A$1.61 M-44.28%
2014A$2.9 M129.45%
2013A$1.26 M-19.85%
2012A$1.57 M-127%
2011-A$5.85 Million2044.94%
2010-A$0.28 Million-99.08%
2009-A$29.6 Million-53.32%
2008-A$63.39 Million-21.76%
2007-A$81.02 Million351.81%
2006-A$17.94 Million230.51%
2005-A$5.43 Million-219.33%
2004A$4.54 M-58.79%
2003A$11.03 M-196.03%
2002-A$11.5 Million